Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of anticoagulant and antiplatelet drugs. Its structure supports binding to specific enzyme targets involved in blood clotting pathways. Also investigated for potential bioactivity in anti-inflammatory and antimicrobial formulations due to the presence of chloroacetamide and heterocyclic moieties. Employed in research settings for structure-activity relationship (SAR) studies aimed at optimizing drug efficacy and selectivity. Primarily used in laboratory research and not widely commercialized.